REBECCA TOLER: Open Payments
NPI 1780398297 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,397 in 116 payments from 22 companies in 2025. Trend: 2023 $15 · 2024 $587 · 2025 $2,397
Food & beverage: $2,213Education: $184
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $313 |
| Regeneron Healthcare Solutions, Inc. | 11 | $299 |
| United Therapeutics Corporation | 10 | $211 |
| GlaxoSmithKline, LLC. | 14 | $188 |
| Actelion Pharmaceuticals US, Inc. | 6 | $180 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $171 |
| Insmed, Inc. | 7 | $170 |
| Merck Sharp & Dohme LLC | 9 | $160 |
| GENZYME CORPORATION | 5 | $130 |
| ANI Pharmaceuticals, Inc. | 5 | $119 |
Products named: DUPIXENT, Tyvaso, OPSUMIT, FASENRA, PURIFIED CORTROPHIN GEL, ZERBAXA, NUCALA, Arikayce.
Industry payments across NC — which companies pay providers there.
